Status:
COMPLETED
Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Oral Contraceptive
Eligibility:
FEMALE
18-49 years
Phase:
PHASE3
Brief Summary
To evaluate the contraceptive efficacy of an oral contraceptive containing a combination of LNG 90 mg/EE 20 mg in a continuous-use regimen and to evaluate the safety compared to LNG 100 mg/EE 20 mg fo...
Eligibility Criteria
Inclusion
- Healthy women aged 18 to 49 years who are willing to rely upon a combination birth control pill as their only method of contraception.
- Women must be sexually active and at risk for becoming pregnant.
- Women must have had regular (21- to 35- day) menstrual cycles for the 3-month period preceding study visit 1.
Exclusion
- High blood pressure
- Age greater then 34 and smoking more than 15 cigarettes per day.
- Depression requiring hospitalization or associated with suicidal ideation within the last 3 years.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
October 1 2004
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00248963
End Date
October 1 2004
Last Update
May 19 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.